UBS AM’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
Other funds holding OVID
UBS AM's OVID Position: Q3 2026 in Review
UBS AM opened a new position in Ovid Therapeutics (OVID) in Q3 2026: 695 shares worth $1.73K. The stake represents ﹤0.01% of the portfolio and ranks #4063 among its holdings.
107 funds tracked by Wall St. Rank hold OVID as of Q3 2026.
- UBS AM held 695 shares of Ovid Therapeutics worth $1.73K as of Q3 2026.
- Ovid Therapeutics was a new UBS AM position in Q3 2026.
- Ovid Therapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4063 holding.
- 107 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.